SCHEMBL15324547

SCHEMBL15324547

O=C(/C=C/c1ccc(O)c(O)c1)OCCCO

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 13/20 0.89
▸ TTR P02766 5/20 0.67
▸ DPP4 P27487 1/20 0.67
▸ CYP3A4 P08684 2/20 0.65
▸ ALOX15 P16050 2/20 0.65
▸ ALOX12 P18054 2/20 0.65
▸ MAPK1 P28482 2/20 0.65
▸ HSD17B10 Q99714 2/20 0.65
▸ AKR1B10 O60218 2/20 0.65
▸ AKR1B1 P15121 2/20 0.65
▸ KDM4E B2RXH2 1/20 0.65
▸ MEN1 O00255 1/20 0.65
▸ GMNN O75496 1/20 0.65
▸ ALDH1A1 P00352 1/20 0.65
▸ EGFR P00533 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ ESR1 P03372 1/20 0.65
▸ ERBB2 P04626 1/20 0.65
▸ LCK P06239 1/20 0.65
▸ FYN P06241 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15312808 1.00 APP (0.89) APPTTRDPP4CYP3A4ALOX15
SCHEMBL27772097 0.91 APP (0.79) APPTTRDPP4CYP3A4ALOX15
SCHEMBL28043642 0.91 APP (0.89) APPTTRDPP4CYP3A4ALOX15
SCHEMBL20883234 0.89 APP (0.83) APPTTRDPP4CYP3A4ALOX15
SCHEMBL8028584 0.89 APP (0.83) APPTTRDPP4CYP3A4ALOX15
Butyl Caffeate SCHEMBL1879822 0.87 APP (1.00) APPTTRDPP4CYP3A4ALOX15
Butyl Caffeate SCHEMBL1879823 0.87 APP (1.00) APPTTRDPP4CYP3A4ALOX15
SCHEMBL28418063 0.86 APP (1.00) APPTTRDPP4CYP3A4ALOX15
SCHEMBL7953562 0.86 APP (1.00) APPTTRDPP4CYP3A4ALOX15
SCHEMBL19358992 0.85 APP (1.00) APPTTRDPP4CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104640540-B Enhanced anti-influenza agents coupled with anti-inflammatory activity 中央研究院 2018-10-09 — — CN disclosed
CN-104640540-A Enhanced anti-influenza agents coupled with anti-inflammatory activity ACADEMIA SINICA 2015-05-20 — — CN disclosed
US-20130274229-A1 ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY ACADEMIA SINICA (TW) 2013-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274229-A1 ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY NEU1, CTSA, CA7 APP 4018/4885TTR 4368/4885DPP4 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback